Center-Authored Papers

Filters: Author is Carpenter, Paul A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
No Keywords
Burroughs LM, Torgerson TR, Storb R, Carpenter PA, Rawlings DJ, Sanders JE, Scharenberg AM, Skoda-Smith S, Englund J, Ochs HD et al..  2010.  Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.. The Journal of allergy and clinical immunology. 126(5):1000-5. Abstract
2008
Furlong T, Kiem H-P, Appelbaum FR, Carpenter PA, Deeg HJ, Doney K, Flowers MED, Mielcarek M, Nash RA, Storb R et al..  2008.  Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(5):531-7. Abstract
Flowers MED, Storer BE, Carpenter PA, Rezvani AR, Vigorito AC, Campregher PV, Moravec C, Kiem H-P, Fero ML, Georges GE et al..  2008.  Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(12):1380-4. Abstract
2009
Mielcarek M, Storer BE, Boeckh MJ, Carpenter PA, McDonald GB, Deeg HJ, Nash RA, Flowers MED, Doney K, Lee SJ et al..  2009.  Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.. Blood. 113(13):2888-94. Abstract
Martin PJ, Storer BE, Rowley SD, Flowers MED, Lee SJ, Carpenter PA, Wingard JR, Shaughnessy PJ, DeVetten MP, Jagasia M et al..  2009.  Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.. Blood. 113(21):5074-82. Abstract
Majhail NS, Flowers MED, Ness KK, Jagasia M, Carpenter PA, Arora M, Arai S, Johnston L, Martin PJ, Baker KS et al..  2009.  High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation.. Bone marrow transplantation. 43(1):49-54. Abstract
Lee SJ, Seaborn T, Mao FJ, Massey SC, Luu NQ, Schubert MA, Chien JW, Carpenter PA, Moravec C, Martin PJ et al..  2009.  Frequency of abnormal findings detected by comprehensive clinical evaluation at 1 year after allogeneic hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(4):416-20. Abstract
Carnevale-Schianca F, Leisenring WM, Martin PJ, Furlong T, Schoch G, Anasetti C, Appelbaum FR, Carpenter PA, Deeg HJ, Kiem H-P et al..  2009.  Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(6):749-56. Abstract
Travi G, Pergam SA, Xie H, Carpenter PA, Kiem H-P, Corey L, Boeckh MJ.  2009.  The effect of imatinib on cytomegalovirus reactivation in hematopoietic cell transplantation.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 49(11):e120-3. Abstract
Vigorito AC, Campregher PV, Storer BE, Carpenter PA, Moravec CK, Kiem H-P, Fero ML, Warren EH, Lee SJ, Appelbaum FR et al..  2009.  Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD.. Blood. 114(3):702-8. Abstract
Sanders JE, Hoffmeister PA, Woolfrey AE, Carpenter PA, Storer BE, Storb R, Appelbaum FR.  2009.  Thyroid function following hematopoietic cell transplantation in children: 30 years' experience.. Blood. 113(2):306-8. Abstract
2010
Burroughs LM, Torgerson TR, Storb R, Carpenter PA, Rawlings DJ, Sanders JE, Scharenberg AM, Skoda-Smith S, Englund J, Ochs HD et al..  2010.  Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.. The Journal of allergy and clinical immunology. 126(5):1000-5. Abstract
Carpenter PA, Macmillan ML.  2010.  Management of acute graft-versus-host disease in children.. Pediatric clinics of North America. 57(1):273-95. Abstract
Verneris MR, Eapen M, Duerst R, Carpenter PA, Burke MJ, Afanasyev BV, Cowan MJ, He W, Krance R, Li C-K et al..  2010.  Reduced-intensity conditioning regimens for allogeneic transplantation in children with acute lymphoblastic leukemia.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(9):1237-44. Abstract
2011
Martin PJ, Storer BE, Carpenter PA, Couriel DR, Flowers MED, Gupta V, Hsu JW, Jagasia M, Kitko CL, Maziarz RT et al..  2011.  Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(1):124-32. Abstract
Martin PJ, Inamoto Y, Carpenter PA, Lee SJ, Flowers MED.  2011.  Treatment of chronic graft-versus-host disease: Past, present and future.. The Korean journal of hematology. 46(3):153-63. Abstract
Inamoto Y, Flowers MED, Lee SJ, Carpenter PA, Warren EH, Deeg HJ, Storb R, Appelbaum FR, Storer BE, Martin PJ.  2011.  Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation.. Blood. 118(2):456-63. Abstract
Mitchell SA, Jacobsohn D, Thormann Powers KE, Carpenter PA, Flowers MED, Cowen EW, Schubert MM, Turner ML, Lee SJ, Martin PJ et al..  2011.  A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(11):1619-29. Abstract
Inamoto Y, Flowers MED, Appelbaum FR, Carpenter PA, Deeg HJ, Furlong T, Kiem H-P, Mielcarek M, Nash RA, Storb R et al..  2011.  A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(7):1088-92. Abstract
Woodard P, Carpenter PA, Davies SM, Gross TG, He W, Zhang M-J, Horn BN, Margolis DA, Perentesis JP, Sanders JE et al..  2011.  Unrelated donor bone marrow transplantation for myelodysplastic syndrome in children.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(5):723-8. Abstract
Nemecek ER, Ellis K, He W, Bunin NJ, Bajwa RS, Cheerva A, Cairo MS, Dvorak C, Duval M, Davies S et al..  2011.  Outcome of myeloablative conditioning and unrelated donor hematopoietic cell transplantation for childhood acute lymphoblastic leukemia in third remission.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(12):1833-40. Abstract
Flowers MED, Inamoto Y, Carpenter PA, Lee SJ, Kiem H-P, Petersdorf EW, Pereira S, Nash RA, Mielcarek M, Fero ML et al..  2011.  Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.. Blood. 117(11):3214-9. Abstract
Cutler C, Kesselheim A, Gabardi S, Andersson BS, Carpenter PA, Khoury HJ, Litzow M, Rowley SD, Lanum S, Leather H et al..  2011.  Generic immunosuppressants in hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):285-90.
Sanders JE, Woolfrey AE, Carpenter PA, Storer BE, Hoffmeister PA, Deeg HJ, Flowers MED, Storb R.  2011.  Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia.. Blood. 118(5):1421-8. Abstract
Carpenter PA.  2011.  How I conduct a comprehensive chronic graft-versus-host disease assessment.. Blood. 118(10):2679-87. Abstract